Skip to main content
. Author manuscript; available in PMC: 2018 May 11.
Published in final edited form as: Circulation. 2017 Apr 7;135(24):2320–2332. doi: 10.1161/CIRCULATIONAHA.116.024360

Table 3.

Frequency of Test Findings and Association With Clinical Events for Anatomic and Functional Testing*

Initial Test Results Anatomic Testing (N=4500) Functional Testing (N=4602)
Frequency
n/N (%)
Event Rate
n/N (%)
HR (95% CI) P Value Frequency
n/N (%)
Event Rate
n/N (%)
HR (95% CI) P Value
All-cause death/myocardial infarction/unstable angina
 Severely abnormal 266/4500 (5.91) 28/266 (10.53) 10.13 (5.15–19.92) <0.0001 365/4602 (7.93) 35/365 (9.59) 3.88 (2.58–5.85) <0.0001
 Moderately abnormal 268/4500 (5.96) 21/268 (7.84) 7.67 (3.83–15.37) <0.0001 217/4602 (4.72) 13/217 (5.99) 2.65 (1.46–4.83) 0.0014
 Mildly abnormal 2461/4500 (54.69) 74/2461 (3.01) 2.94 (1.64–5.26) 0.0003 432/4602 (9.39) 9/432 (2.08) 0.94 (0.47–1.89) 0.8666
 Normal 1505/4500 (33.44) 14/1505 (0.93) 3588/4602 (77.97) 75/3588 (2.09)
Cardiovascular death/myocardial infarction/unstable angina
 Severely abnormal 266/4500 (5.91) 26/266 (9.77) 17.26 (7.55–39.46) <0.0001 365/4602 (7.93) 31/365 (8.49) 4.59 (2.93–7.19) <0.0001
 Moderately abnormal 268/4500 (5.96) 18/268 (6.72) 12.03 (5.14–28.19) <0.0001 217/4602 (4.72) 13/217 (5.99) 3.50 (1.89–6.48) <0.0001
 Mildly abnormal 2461/4500 (54.69) 57/2461 (2.32) 4.08 (1.93–8.66) 0.0002 432/4602 (9.39) 8/432 (1.85) 1.11 (0.53–2.34) 0.7834
 Normal 1505/4500 (33.44) 8/1505 (0.53) 3588/4602 (77.97) 56/3588 (1.56)
Cardiovascular death/myocardial infarction
 Severely abnormal 266/4500 (5.91) 9/266 (3.38) 4.87 (1.72–13.75) 0.0028 365/4602 (7.93) 14/365 (3.84) 2.13 (1.16–3.91) 0.0141
 Moderately abnormal 268/4500 (5.96) 5/268 (1.87) 3.09 (0.96–9.97) 0.0594 217/4602 (4.72) 5/217 (2.30) 1.53 (0.60–3.90) 0.3681
 Mildly abnormal 2461/4500 (54.69) 39/2461 (1.58) 2.73 (1.20–6.25) 0.0170 432/4602 (9.39) 5/432 (1.16) 0.81 (0.32–2.04) 0.6542
 Normal 1505/4500 (33.44) 7/1505 (0.47) 3588/4602 (77.97) 48/3588 (1.34)

CI indicates confidence interval; and HR, hazard ratio. Nonobstructive coronary artery disease is defined as 1% to 69% of stenosis.

*

Secondary test result stratification sets computed tomographic angiography threshold for moderate abnormality to 70%.